NCT07111221View on ClinicalTrials.gov

Portal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss

NARecruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

June 24, 2025

Primary Completion Date

October 31, 2029

Study Completion Date

December 31, 2029

Conditions
Liver CirrhosisClinically Significant Portal Hypertension
Interventions
PROCEDURE

Transjugular Intrahepatic Portosystemic Shunt

Transjugular Intrahepatic Portosystemic Shunt performed prior to liver transplantation in patients with increased risk of intraoperative blood loss

DRUG

Non-selective beta-blockers

Non-selective beta-blockers for lowering portal hypertension

Trial Locations (1)

Unknown

RECRUITING

University Clinical Centre of the Medical University of Warsaw, Warsaw

Sponsors
All Listed Sponsors
collaborator

Medical Research Agency, Poland

OTHER_GOV

lead

Medical University of Warsaw

OTHER

NCT07111221 - Portal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss | Biotech Hunter | Biotech Hunter